Gfpc Investigation

This study looks at people with metastatic lung cancer who have lived for at least three years after diagnosis and are no longer on chemotherapy. Researchers want to learn about their health, daily life, and any challenges they face. Participants will fill out questionnaires abou…

This study is for adults aged 70 and older with non-small cell lung cancer who are starting their first treatment. Researchers will observe how well standard treatments work in everyday practice, including their effects on cancer progression, side effects, and quality of life. Th…

This study is watching how well a treatment combining amivantamab and chemotherapy works in everyday medical practice for adults with metastatic non-small cell lung cancer that has certain EGFR gene changes. About 100 people who are already getting this treatment through an early…